Pharmacielo Ltd's stock has seen a notable decline this week, reflecting broader market challenges.
Pharmacielo Ltd (PCLO.V) closed at C$0.05, unchanged from the previous day but down 8.33% over the past week. This follows a trend of sharp declines year-to-date, with the stock down 59.26% in 2023. Despite its struggles, analysts maintain a bullish outlook with an average target of C$2.50, suggesting a potential upside of nearly 4900%.
Advertisement
Pharmacielo Ltd
PCLO.V
PCLO.V
Pharmacielo Ltd
WealthAwesomeMarket cap
$11.01M
52W high
$0.17
52W low
$0.04
1W change
-8.33%
Beta
0.62
Analyst Price Targets
Based on analyst covering PCLO · as of Sep 17, 2026
Wall Street analysts forecast PCLO stock price to rise 4445.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.50
+4445.5% Upside
Current Price
C$0.06
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PCLO's historical volatility
30-Day Vol
137.3%
Annualized
90-Day Vol
176.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.05 | C$0.03 – C$0.08 |
| 60 trading days | C$0.05 | C$0.02 – C$0.10 |
| 90 trading days | C$0.05 | C$0.02 – C$0.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: While Pharmacielo Ltd's stock has faced significant challenges, the bullish analyst outlook may offer some hope for long-term investors. However, the current technical indicators suggest caution due to the stock's persistent underperformance.
Pharmacielo Ltd's stock is down 59.26% year-to-date.
With a market cap of just C$11 million, the company's financials reflect significant operational challenges, leading to a substantial decline in stock performance.
Bull case
Analysts are optimistic about Pharmacielo Ltd, with an average target of C$2.50, indicating significant potential upside. The company's position in the health care sector could benefit from future regulatory changes and increased demand for cannabis-related products. This optimism suggests that if the market conditions improve, there could be a strong rebound for the stock.
Bear case
The stock has shown a consistent decline, with a profit margin of -103.1% and a return on equity (ROE) of -3013.2%. These negative performance metrics, combined with the current trading price below both the 50-day and 200-day moving averages, indicate ongoing operational challenges. Investors should be cautious as these trends suggest the company may continue to struggle in the near term.
Price Action Overview
Pharmacielo Ltd's stock closed at C$0.05 today, reflecting no change from the previous trading session. However, the stock has seen a decline of 8.33% over the past week and is down 59.26% year-to-date. The latest trading volume was 17,575 shares, significantly higher than the 20-day average volume of 93,505 shares, indicating increased trading activity.
Advertisement
Technical Picture
Currently, Pharmacielo Ltd is trading below both its 50-day moving average of C$0.06 and its 200-day moving average of C$0.07, suggesting a bearish trend. The stock's 52-week range has been C$0.04 to C$0.17, with the current price at 12% of this range. With a beta of 0.62, the stock has shown lower volatility compared to the overall market.
Insider Activity
No insider activity has been reported for Pharmacielo Ltd this week, indicating that there may not be significant changes in ownership or confidence from internal stakeholders.
Market Sentiment and Analyst Ratings
Despite the stock's struggles, analysts maintain a bullish outlook with an average target of C$2.50, implying a potential upside of 4900%. This optimism may stem from anticipated growth in the health care sector, particularly in cannabis-related products, as regulatory environments evolve.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
